Science Writer
at Technology Networks
Isabel is a Science Writer and Editor at Technology Networks . She holds a BSc in exercise and sport science from the University of Exeter, a MRes in medicine and health and a PhD in medicine from the University of Nottingham. Her doctoral research explored the role of dietary protein and exercise in optimizing muscle health as we age.
Education
Areas of Expertise
Got a Question for Isabel Ely, PhD?
Get in touch using the contact form linked here and we'll get back to you shortly.
Published Content
Total: 35
News
AstraZeneca's Drug Approved for Treating Limited-Stage Small Cell Lung Cancer in Europe
IMFINZITM (durvalumab) has received approval in the European Union as a monotherapy for treating adults with limited-stage small cell lung cancer (LS-SCLC) whose disease has not progressed after platinum-based chemoradiation therapy.
Article
Why Endometriosis Takes So Long To Diagnose and Treat
Endometriosis affects 1 in 10 women, yet diagnosis takes nearly a decade, leading to prolonged pain, infertility and organ damage. Improved awareness, research and reduced wait times are crucial for earlier detection and better patient outcomes.
News
Cancer Immunotherapy Enhanced by Rewiring T-Cell Metabolism
Researchers from the VIB-KU Leuven Center for Cancer Biology, in collaboration with other scientists, have discovered a way to enhance the immune system's ability to fight cancer by reprogramming T-cell metabolism.
News
Researchers Find Possible Link Between Aspirin and Reduced Cancer Metastasis
A new study led by researchers at the University of Cambridge has revealed the mechanism behind how aspirin could reduce metastasis of some cancers by stimulating the immune system.
News
Can CRISPR Offer a Cure for Prader-Willi Syndrome?
Recent research from Duke University has demonstrated a promising new approach that could be used to treat a rare and complex class of genetic diseases, such as PWS, caused by defects in a relatively large region of the genome.
News
Synthetic Microbiome Therapy Offers Safer Alternative to Fecal Transplants
Scientists develop a synthetic microbiome therapy to fight C. difficile infections offering a safer, targeted alternative to fecal transplants.
Article
Ultra-Rapid Test Helps Identify Cancerous Cells in Real Time
In this interview, Technology Networks spoke with Dr. Gilad Evrony, assistant professor at NYU Grossman School of Medicine, to learn more about a novel tool for rapidly identifying cancer cells in the operating room.
Article
The Role of Stable Isotope Tracers in Skeletal Muscle Metabolism Research
Stable isotope amino acid tracers have been pivotal in understanding muscle protein synthesis and breakdown, helping reveal the cause of age-related muscle decline sarcopenia and uncovering other key insights into human health.
News
Case Study Reveals Rare Side Effect of CAR T-Cell Therapy
A new study from researchers at the University of Leipzig Medical Center and collaborators, has discovered a rare but serious side effect of CAR T-cell therapy in a 63-year-old patient.
News
Cancer Cells Don’t Just Compete, They Cooperate
Researchers from New York University have uncovered that cancer cells also work together to source nutrients from their environment — a cooperative process that was previously overlooked but may be a promising target for treating cancer.
Advertisement
